Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -9.18%.However, over the last six months, we can see a weaker performance of 67.11%. Over the last 30 days, the price of PRME has leaped by -11.19%. And in the last five days, it has fallen by -6.39%.
At present, Prime Medicine Inc (PRME) has a stock price of $3.81. In the previous session, the stock saw a rise, peaking at $10.0 after an opening price of $3.81. The day’s lowest price was $4.0, and it closed at $3.46.
Prime Medicine Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $5.17 on 07/21/25, while the lowest price for the same period was registered at $1.11 on 05/22/25.
52-week price history of PRME Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Prime Medicine Inc’s current trading price is -26.31% away from its 52-week high, while its distance from the 52-week low is 243.24%. The stock’s price range during this period has varied between$1.11 and $5.17. The Prime Medicine Inc’s shares, which operate in the Healthcare, saw a trading volume of around 3.18 million for the day, a figure considerably lower than their average daily volume of 4.19 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Prime Medicine Inc (PRME) has experienced a quarterly rise of 200.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 678.93M and boasts a workforce of 214 employees.
Prime Medicine Inc: Analysts’ Ratings Unveiled
As of right now, 7 analysts are rating Prime Medicine Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.34, with a change in price of +1.80. Similarly, Prime Medicine Inc recorded 3,236,118 in trading volume during the last 100 days, posting a change of +89.55%.
PRME’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PRME stands at 1.97. Similarly, the long-term debt-to-equity ratio is also 1.85.
PRME Stock Stochastic Average
Prime Medicine Inc’s raw stochastic average for the past 50 days is presently 65.74%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 25.27%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 11.41% and 10.06%, respectively.
